Results 181 to 190 of about 210,637 (269)

Comparison of euploidy rates between progestin-primed ovarian stimulation and GnRH antagonist protocols: a single-center study in a mixed-ethnicity population. [PDF]

Front Endocrinol (Lausanne)
Ingold C, Dos Santos GG, Barbosa CP, De Oliveira R.   +3 more
europepmc   +1 more source

Effect of vaginal estrogen supplementation for luteal phase support in the GnRH antagonist protocol on pregnancy outcomes for IVF/ICSI cycles: a randomized controlled trial. [PDF]

Hum Reprod Open
Yang X, Zhu L, Chen R, Lin T, Le F, Zhan Q, Gao H, Wang F, Zhu Y, Lou H.   +9 more
europepmc   +1 more source

Modified letrozole vs GnRH antagonist protocols in ovarian aging women for IVF: an open-label, multicenter, randomized controlled trial. [PDF]

Nat Commun
Zhao Y, Zhao S, Xu J, Chen J, Lin Y, Peng Y, Li X, Pan P, Shu J, Li X, Wang J, Chu C, Hu R, Yu Y, Zhang Y, Rehman SU, Dong G, Yang D, Azziz R, Mol BW, Xia Y, Zhao X.   +21 more
europepmc   +1 more source

A drop in serum estradiol levels during GnRH antagonist cotreatment in cycles stimulated with gonadotropins is associated with lower cumulative live birth rates. [PDF]

Front Endocrinol (Lausanne)
Janssens L, Roelant E, Blockeel C, De Neubourg D.   +3 more
europepmc   +1 more source

Medroxyprogesterone acetate vs. GnRH antagonist for preventing premature LH surge during ovarian stimulation in assisted reproductive technology: a retrospective cohort study. [PDF]

Front Reprod Health
Jimenez MM, Jesam C, Sequeira K, Alcantar K.   +3 more
europepmc   +1 more source

Progestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation. [PDF]

Sci Rep
Meseci E, Okten SB, Bilgen S, Ozveri H, Ocal N, Ozdemir B, Fıcıcıoglu C.   +6 more
europepmc   +1 more source

Impact of GnRH antagonist protocols versus progestin-primed ovarian stimulation on reproductive outcomes in advanced reproductive age women: a propensity score-matched retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Qi Z, Wang T, Ren J, Zhao S, Song J, Lian F, Zhao Y.   +6 more
europepmc   +1 more source

An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol. [PDF]

J Ovarian Res
Zhao L, Fan G, Wang W, Zhou C.
europepmc   +1 more source

Flexible progestin-primed ovarian stimulation is a safe and effective alternative to GnRH antagonist protocol in PGT-A cycles. [PDF]

Turk J Obstet Gynecol
Turgut NE, Özmen S, Kar E, Benli H, Bastu E.   +4 more
europepmc   +1 more source

A Case of Familial Mediterranean Fever Diagnosed After Oral Administration of a Gonadotropin-Releasing Hormone (GnRH) Antagonist. [PDF]

Cureus
Ueno H, Ohara R, Nakao S, Sasaki J, Satoh T.   +4 more
europepmc   +1 more source